Origin Asset Management LLP Emergent Bio Solutions Inc. Transaction History

Origin Asset Management LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $254,745 - $362,070	-4,500 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $43,115 - $62,595	-500 Reduced 10.0%	4,500 $418,000
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $35,151 - $49,492	-444 Reduced 8.16%	5,000 $448,000
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $445,918 - $734,613	5,444 New	5,444 $563,000

137

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $395M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.